{
    "clinical_study": {
        "@rank": "110916", 
        "arm_group": [
            {
                "arm_group_label": "Complementary medicine counseling", 
                "arm_group_type": "Experimental", 
                "description": "Patients receiving chemotherapy who are referred by their oncology provider to complementary medicine consultation and treatment provided in addition to conventional supportive care"
            }, 
            {
                "arm_group_label": "Conventional supportive care", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients receiving conventional supportive care"
            }
        ], 
        "brief_summary": {
            "textblock": "In 2007, the Haifa and Western Galilee district of the CHS set out to test the feasibility\n      of integrating complementary medicine (CM) within the CHS Oncology Service. In 2008, the CHS\n      established the Integrative Oncology Program with the goal of addressing patient concerns\n      and improving quality of life parameters during chemotherapy and advanced disease. The study\n      hypothesis is that integrated medicine consultation and treatment provided within the\n      oncology department may improve patients' concerns and well-being."
        }, 
        "brief_title": "Measuring Concerns of Cancer Patients Referred to Complementary Medicine Treatment Integrated Within Oncology Service", 
        "completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Quality of Life", 
        "detailed_description": {
            "textblock": "In 2007, the Haifa and Western Galilee district of the CHS set out to test the feasibility\n      of integrating complementary medicine (CM) within the CHS Oncology Service. In 2008, the CHS\n      established the Integrative Oncology Program with the goal of addressing patient concerns\n      and improving quality of life parameters during chemotherapy and advanced disease. The study\n      is purposed to assess concerns, needs and perspectives of patients referred to integrative\n      consultation during chemotherapy and/or advanced cancer; to characterize social demographic\n      and health parameters of patients who consult or avoid integrative medicine consultation; to\n      document complementary medicine use prior and during consultation; to assess if\n      complementary medicine consultation and treatment improve patient's concerns and well-being;\n      and to assess oncology provider and integrative practitioner communications issues\n      concerning integrative care."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with cancer diagnosis receiving chemotherapy and/or surgical treatment who\n             are referred by their oncology provider to complementary medicine consultation\n\n          -  Age older than 18 years\n\n        Exclusion Criteria:\n\n          -  Age younger than 18 years"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "980", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01860365", 
            "org_study_id": "CMC-09-0024-CTIL"
        }, 
        "intervention": [
            {
                "arm_group_label": "Complementary medicine counseling", 
                "description": "Patients receiving chemotherapy will be referred by their oncology provider to complementary medicine (CM) consultation and treatment provided in addition to conventional supportive care.CM consultation will include assessment of patients' concerns and well-being, current CM use (including herbal and nutritional supplements), and construction of CM treatment based on efficacy and safety considerations.", 
                "intervention_name": "Complementary medicine consultation and treatment", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Conventional supportive care", 
                "description": "Patients receiving chemotherapy will be offered assessment of their concerns and well-being as well as their current complementary medicine (CM) use (including herbal and nutritional supplements). Patients in this arm study will receive conventional supportive care with no added CM consultation or treatment.", 
                "intervention_name": "Patients receiving  conventional supportive care", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Quality of life", 
            "Integrative medicine", 
            "Supportive care", 
            "Cancer", 
            "Chemotherapy"
        ], 
        "lastchanged_date": "May 12, 2014", 
        "location": {
            "contact": {
                "email": "eranbe@clalit.org.il", 
                "last_name": "Eran Ben-Arye, MD", 
                "phone": "972528709282", 
                "phone_ext": "0"
            }, 
            "contact_backup": {
                "email": "ilanitsh10@walla.co.il", 
                "last_name": "Ilanit Shalom-Sharabi, RN MA", 
                "phone": "97252948423", 
                "phone_ext": "0"
            }, 
            "facility": {
                "address": {
                    "city": "Haifa", 
                    "country": "Israel", 
                    "zip": "35152"
                }, 
                "name": "Lin Zebulon and Carmel Medical centers"
            }, 
            "investigator": {
                "last_name": "Ilanit Shalom-Sharabi, RN MA", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "Measuring Concerns and Needs of Cancer Patients Referred to Complementary Medicine Treatment Integrated Within the Oncology Service", 
        "other_outcome": {
            "description": "Documentation in registry protocol of patients' reported side-effects concerning complementary medicine treatments", 
            "measure": "Complementary medicine side-effects documentation", 
            "safety_issue": "Yes", 
            "time_frame": "6-12 weeks(+follow-up 4 months)"
        }, 
        "overall_official": {
            "affiliation": "Clalit Health Services", 
            "last_name": "Eran Ben-Arye, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ethics Commission", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Assessing patients'concerns and Wellbeing as well as narrative assessment of integrative care outcomes", 
                "measure": "MYCAW (Measure Yourself Concerns and Wellbeing)questionnaire", 
                "safety_issue": "No", 
                "time_frame": "6-12 weeks(+follow-up 4 months)"
            }, 
            {
                "description": "Assessing the severity of 10 leading symptoms and well-being", 
                "measure": "ESAS (Edmonton Symptom Assessment Scale)questionnaire", 
                "safety_issue": "No", 
                "time_frame": "6-12 weeks(+follow-up 4 months)"
            }, 
            {
                "description": "The EORTC quality of life questionnaire (QLQ) is an integrated system for assessing the health related quality of life of cancer patients. The questionnaire includes functional and symptom scales.", 
                "measure": "EORTC QLQ-C30", 
                "safety_issue": "Yes", 
                "time_frame": "6-12 weeks(+follow-up 4 months)"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01860365"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Carmel Medical Center", 
            "investigator_full_name": "Eran Ben-Arye", 
            "investigator_title": "Integrative oncology Program, Director", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Assessing patients' spiritual well-being", 
                "measure": "FACIT-Sp-12 questionnaire", 
                "safety_issue": "No", 
                "time_frame": "2-4 months"
            }, 
            {
                "description": "Assessment of patients' attitudes concerning complementary medicine (CM)safety and efficacy, health beliefs concerning mind-body interactions, and willingness to receive CM treatments", 
                "measure": "Attitudes concerning complementary medicine", 
                "safety_issue": "Yes", 
                "time_frame": "6-12 weeks"
            }
        ], 
        "source": "Carmel Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Carmel Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2009", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}